Mpox Outbreak: 314 Cases and 5 Deaths Reported in 22 Counties

The Ministry of Health has confirmed 314 Mpox cases and five related deaths across 22 counties in Kenya so far.

In response to the rising numbers, the Ministry has issued strong advisories urging the public to take extra precautions to help stop the spread of the disease. Kenyans are being asked to avoid close contact with people showing symptoms of Mpox, especially those with skin rashes or sores, and to take protective measures when caring for someone who may be infected.

The ministry has also emphasized the importance of using personal protective equipment like gloves and face masks when handling patients or contaminated materials. People are strongly advised not to share items such as bedding, towels, or clothing with anyone who is sick or suspected of being infected with Mpox.

The outbreak has now affected 22 counties, though health officials have not yet released a full list of the affected areas. The Ministry continues to monitor the situation and carry out contact tracing and case management to help control the spread.

Mpox, formerly known as monkeypox, is a viral disease that spreads mainly through close personal contact with an infected person, contaminated surfaces, or body fluids. The disease often begins with fever, muscle aches, swollen lymph nodes, and eventually develops into a rash or sores, usually on the face, hands, or other parts of the body.

Although many Mpox cases can be mild and recoverable with supportive care, health experts warn that severe illness and complications can occur, particularly for people with weakened immune systems or pre-existing health conditions.

The Ministry is calling on county governments, community health workers, and local health facilities to raise public awareness and improve early detection and reporting. Surveillance has been heightened, and medical teams have been dispatched to assist with response efforts in the affected regions.

As the number of cases continues to rise, health officials are reminding the public to stay vigilant, practice good hygiene, and seek medical help promptly if symptoms appear. The Ministry says further updates will be provided as the situation develops.

Health

First U.S. Human Case of Travel-Linked Screwworm Confirmed by HHS
First U.S. Human Case of Travel-Linked Screwworm Confirmed by HHS

The U.S. has confirmed its first human case of New World Screwworm infestation linked to international travel, health officials announced.

Africa CDC Reports Drop in Mpox Cases, Warns of New Outbreaks
Africa CDC Reports Drop in Mpox Cases, Warns of New Outbreaks

The Africa Centres for Disease Control and Prevention (Africa CDC) has reported a major 58 per cent drop in mpox cases across the continent between epidemiological week 19 and week 30 of 2025.

CS Duale Suspends 40 Hospitals Over SHA Insurance Fraud
CS Duale Suspends 40 Hospitals Over SHA Insurance Fraud

Defence Cabinet Secretary Aden Duale has suspended 40 hospitals and 12 health officials over allegations of defrauding the Social Health Authority (SHA) system.

RFK Jr. Cancels $500M in mRNA Vaccine Projects Over Safety Concerns
RFK Jr. Cancels $500M in mRNA Vaccine Projects Over Safety Concerns

The U.S. government is canceling $500 million worth of vaccine development projects that use mRNA technology, Health and Human Services (HHS) Secretary Robert F.

Nigerian Nurses Suspend Strike After Talks With Government
Nigerian Nurses Suspend Strike After Talks With Government

The nationwide warning strike by Nigerian nurses and midwives has been suspended following a closed-door meeting with government officials.

WHO Labels Hepatitis D a Cancer Risk, Urges Global Action
WHO Labels Hepatitis D a Cancer Risk, Urges Global Action

The World Health Organization (WHO) has classified Hepatitis D as a cancer-causing virus, warning that it significantly increases the risk of liver cancer in people already infected with Hepatitis B.

Dei BioPharma Earns U.S. Patents for Game-Changing Therapies
Dei BioPharma Earns U.S. Patents for Game-Changing Therapies

In a major step forward for global healthcare, Uganda’s Dei BioPharma has secured two U.S. patents for breakthrough therapies aimed at making cancer and immune treatments more affordable and accessible.

Other Stories